# TargED Biopharmaceuticals B.V

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/targed-biopharmaceuticals-b-v

- Industry: Biotechnology
- Headquarters: Utrecht, Netherlands
- Website: www.targedbiopharmaceuticals.com
- Total disclosed funding: $71M
- Latest round: Series A (Dec 16, 2025)
- Investors on record: 9

## About

Based in Utrecht, Netherlands, and founded in 2018 by CEO Kristof Vercruysse and co-founders Marc van Moorsel, Steven de Maat, and Coen Maas. TargED Biopharmaceuticals B.V is a biotechnology company that develops biological drugs to improve the treatment of thrombosis.In December 2025, TargED Biopharmaceuticals B.V raised EUR 21.5 million in series A funding led by BioGeneration Ventures, with participation from existing investors including Andera Partners, Fund+, Hadean Ventures, Inkef, Sunstone Life Science Ventures and Curie Capital.

TargED Biopharmaceuticals B.V develops drugs by using small antibodies to deliver enzymes to sites of thrombosis, enabling targeted thrombolysis. Its lead product is a Microlyse clot-busting compound that binds to a protein present in all forms of thrombosis. Its mechanism of action allows for potential applications in a variety of indications involving thrombosis, including the life-threatening disease Thrombotic Thrombocytopenic Purpura. 

The company will use the series A funding to advance clinical programs, start early-stage trials, and develop treatments for thrombotic conditions.

## Funding rounds

- Series A, Dec 16, 2025, $25M — Andera Partners, BioGeneration Ventures, Inkef, Hadean Ventures, Fund+, Curie Capital, Sunstone Life Science Ventures
- Series A, Feb 22, 2022, $44M — Andera Partners, Inkef, Hadean Ventures, Fund+, Curie Capital, Sunstone Life Science Ventures, Fonds InvesteringsRijpe Starters, Utrecht Holdings
- Seed, Nov 24, 2020, $1.6M — Curie Capital, Fonds InvesteringsRijpe Starters, Utrecht Holdings

## Investors

- Curie Capital (https://capitalatlas.ai/funds/curie-capital) — Seed, Series A
- Fonds InvesteringsRijpe Starters — Seed, Series A
- Utrecht Holdings (https://capitalatlas.ai/funds/utrecht-holdings) — Seed, Series A
- Andera Partners (https://capitalatlas.ai/funds/andera-partners) — Series A
- Inkef (https://capitalatlas.ai/funds/inkef) — Series A
- Hadean Ventures (https://capitalatlas.ai/funds/hadean-ventures) — Series A
- Fund+ (https://capitalatlas.ai/funds/fund) — Series A
- Sunstone Life Science Ventures (https://capitalatlas.ai/funds/sunstone-life-science-ventures) — Series A
- BioGeneration Ventures (https://capitalatlas.ai/funds/biogeneration-ventures) — Series A